Safety of intracoronary administration of c-myc antisense oligomers after percutaneous transluminal coronary angioplasty (PTCA).
Roqué F, Mon G, Belardi J, Rodriguez A, Grinfeld L, Long R, Grossman S, Malcolm A, Zon G, Ormont ML, Fischman DL, Shi Y, Zalewski A.
Roqué F, et al. Among authors: long r.
Antisense Nucleic Acid Drug Dev. 2001 Apr;11(2):99-106. doi: 10.1089/108729001750171335.
Antisense Nucleic Acid Drug Dev. 2001.
PMID: 11334145
Clinical Trial.